Nanotechnology in Cancer Treatment and Detection. Richard Acosta
|
|
- Percival Long
- 8 years ago
- Views:
Transcription
1 Nanotechnology in Cancer Treatment and Detection Richard Acosta
2 Motivation Ineffectiveness of many Cancer treatments Numerous side effects Difficulties in early Cancer detection No immunization
3 Scale and Scope The nanoparticles discussed in this presentation are typically between nm or roughly 100 times smaller than most human cells Cancer Nanotechnology research is interdisciplinary and incorporates Biology, Chemistry, Engineering, Medicine, and Physics
4 Properties of Cancer Cells Epidermal Growth Factor Receptor (EGFR) over expression and over activity have been associated many different types of Cancer Cancer cells have a unique properties that can be exploited by nanoparticles Their rapid rate of growth causes them to intake an abnormal amount of nutrients (i.e., folic acid) Nanoparticles can be used to target bio-markers or antigens that are highly specific to Cancer cells
5 Nanoparticle Specialization 99% of chemotherapy drugs do not reach the Cancer cells Nanotubes, nanorods, dendrimers, nanospheres, nanoantennas, using carbon, iron, gadolinium, gold, silicon, etc. Antigen binding peptide ligands are attached to the nanostructures Folic acid baiting Passive targeting - Leaky blood vessels near tumors cause the nanoparticles to cluster around the tumors
6 Uses in Treatment Intracellular Drug Delivery The Trojan Horse Cytotoxic chemical payload Methotrexate, Docetaxel, etc
7 Uses in Treatment Experiment on mice bearing human prostate tumors After approximately 3 months 100% of the mice treated with the targeted nanoparticles survived 57% of the mice treated with untargeted nanoparticles survived 14% of the mice with Docetaxel alone survived Amount of weight loss and white blood cell count confirmed far lower toxicity for the targeted nanoparticles
8 Comparative efficacy study in LNCaP s.c. xenograft nude mouse model of PCa Farokhzad O. C. et.al. PNAS 2006;103: by National Academy of Sciences
9 Uses in Treatment Photothermal Ablation Cancer cells die at 42 C (108 F), normal cells die at about 46 C (115 F) Current optical fiber treatment Hollow, gold nanospheres are 50 times more effective at absorbing light near the infrared than solid gold nanoparticles Nanoparticles can be tuned to be excited only by certain ranges of light
10 Uses in Treatment In another study, pre-clinical trials reveal that a single intravenous nanoparticle injection eradicated 100 percent of tumors in mice when exposed to near-infrared light. Most work is being done with near-infrared light, which is harmless to humans but can only penetrate human tissue about 1.5 inches. Nanoparticles heated up to 70 C (160 F) The Kanzius RF Machine uses radio waves for dielectric heating
11 Uses in Detection Gold nanoparticles in this image showed 600 percent more affinity to Cancer cells than healthy cells (EGFR binding) White light and simple, inexpensive microscope is all that s necessary for powerful ex vivo Cancer detection. The scattering is so strong that even one nanoparticle can be detected.
12 Uses in Detection Using a metal-organic framework with metals such as gadolinium or iron, nanoparticles can be used as MRI contrast agents For the same amount of contrast, only 1/3 of the contrast agent is necessary using nanoparticle targeting
13 Uses in Detection Fluorescent Microscopy Nanoparticles can serve as dual detection devices for both magnetic resonance and microscopy
14 Current Limitations Cancer targeting is highly dependent on surface chemistry. Not just any nanoparticle will work. The need for biocompatible and stable nanoparticles Side-effects and toxicity Environmental impact Uncharted territory
15 Future Human clinical trials within the next 2-3 years Highly specific team of communicating multifunctional nanoparticles used in the discovery, treatment, and prevention of Cancer growth Safer, more consistent, and highly specific nanoparticle production Turning Cancer into a chronic, but manageable disease within the next years
16 Summary -Different types of Cancer cells have unique properties that can be exploited by nanoparticles to target the Cancer cells -Nanoparticles can be used to detect/monitor (by utilizing or adding optic, magnetic, and fluorescent properties) and to treat Cancer (by Heat ablation, chemotherapy, gene therapy). -No human trials have been performed yet and human trials are still at least a few years away. (Unknown side effects, toxicity, difficulty in manufacturing and harmful byproducts, need for highly specific nanoparticles)
17 Sources University of California - Santa Cruz (2009, March 28). Hollow Gold Nanospheres Show Promise For Biomedical And Other Applications. ScienceDaily. Retrieved May 24, 2009, from /releases/2009/03/ htm University of Texas M. D. Anderson Cancer Center (2009, February 8). Targeted Nanospheres Find, Penetrate, Then Fuel Burning Of Melanoma. ScienceDaily. Retrieved May 24, 2009, from /releases/2009/02/ htm Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharmaceutical Research. 2006; 23(7): Sunderland CJ, Steiert M, Talmadge JE, Derfus AM, Barry SE. Targeted nanoparticles for detecting and treating cancer. Drug Development Research. 2006; 67: Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. Journal of Cellular Biochemistry. 2006; 97: El-Sayed, Mostafa. Gold Nanoparticles May Simplify Cancer Detection. Georgia Institute of Technology Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft, Stephen G. Boyes. Polymer-Modified Gadolinium Metal-Organic Framework Nanoparticles Used as Multifunctional Nanomedicines for the Targeted Imaging and Treatment of Cancer. Biomacromolecules (4), Chungang Wang, Jiji Chen, Tom Talavage, Joseph Irudayaraj. Gold Nanorod/Fe3O4 Nanoparticle Nano-Pearl-Necklaces for Simultaneous Targeting, Dual-Mode Imaging, and Photothermal Ablation of Cancer Cells. Angewandte Chemie International Edition (2009) L. Denton, Michael S. Foltz, Gary D. Noojin, Larry E. Estlack, Robert J. Thomas, and Benjamin A. Rockwell. Determination of threshold average temperature for cell death in an in vitro retinal model using thermograph Proc. SPIE 7175, 71750G (2009), DOI: / Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo PNAS : ; published online before print April 10, 2006, doi: /pnas
18 Questions 1) Which of the following are not potential methods for treating Cancer using nanotechnology. a) Photothermal ablation b) Folic acid introduction c) Cytotoxic drug delivery d) Gene therapy e) None of the above 2) A cause for the stall in utilizing nanotechnology treatment on a mass scale is a) Unknown toxic effects of nanoparticles b) Environmental repercussions c) Lack of human clinical trials d) Inefficient nanoparticle creation techniques e) All of the above
Theranostics: A combination of diagnostics and therapy
Theranostics: A combination of diagnostics and therapy Professor Peter Dobson Academic Director Oxford University Begbroke Science Park, Oxford, England Theranostics: the possible scenarios Therapeutic
More informationExploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program
More informationMonoclonal Antibody Therapy: Innovations in Cancer Treatment. James Choi ENGL 202C
Monoclonal Antibody Therapy: Innovations in Cancer Treatment James Choi ENGL 202C Treating Cancer with Monoclonal Antibody Therapy Researchers and scientists have been working for decades to find a cure
More informationA PATIENT S GUIDE TO ABLATION THERAPY
A PATIENT S GUIDE TO ABLATION THERAPY THE DIVISION OF VASCULAR/INTERVENTIONAL RADIOLOGY THE ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL Treatment options for patients with cancer continue to expand, providing
More informationFederal Funding for Technological Revolutions: Biotechnology and Healthcare Highlights
ADVANCED TE CHNOLOGY P ROGRAM The Advanced Technology Program Federal Funding for Technological Revolutions: Biotechnology and Healthcare Highlights April 2006 National Institute of Standards and Technology
More informationCreating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents
Designing for the Frontiers of Research Creating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents Richard J. Mohr What if it were possible to treat a cancer patient
More informationMesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationMEDICAL BREAKTHROUGHS RESEARCH SUMMARY
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: Training the Body to Fight Melanoma REPORT: 3823 BACKGROUND: Melanoma is the most dangerous form of skin cancer that can be hard to treat and fatal if not
More informationSmoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationRadiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.
Dictionary Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment. Applicator A device used to hold a radioactive source
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationThe Clinical Trials Process an educated patient s guide
The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-
More informationNEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.
More informationManaging Joint Venture Arrangements Between Two Biotech Companies: A Case Report. Dr. Jan Mous Midatech / PharMida May 21 st 2014
Managing Joint Venture Arrangements Between Two Biotech Companies: A Case Report Dr. Jan Mous Midatech / PharMida May 21 st 2014 1 Midatech Ltd. Corporate verview Founded 2000 in xford, England Drug development
More informationSUMMARY. Randolph Fillmore, Florida Science Communications
SUMMARY Randolph Fillmore, Florida Science Communications The H. Lee Moffitt Cancer Center held its first Advanced Prostate Cancer Collaboration roundtable discussion November 24, 2008. The roundtable
More informationKey Results of 2008 Leem Nanomedecine Study
Key Results of 2008 Leem Nanomedecine Study Nanobio Dialogue Session Annick Schwebig,, M.D., General Manager, Actelion Pharmaceuticals France Vice-President of Leem Biotech Committee EuroBio,, Paris, October
More informationSimplifying Oncology Care
Simplifying Oncology Care March 2009 Research Philips Research focuses on ultrasound-mediated drug delivery Research Philips Research focuses on ultrasound-mediated drug delivery Philips Research and its
More informationTECHNICAL INSIGHTS TECHNOLOGY ALERT
TECHNICAL INSIGHTS TECHNOLOGY ALERT UNLOCKING BREAST CANCER TUMORS' DRUG RESISTANCE A troubling phenomenon in breast cancer treatment is that some patients tumors become resistant to treatments over time.
More informationSummary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs
Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer
More informationSPECT and PET imaging in porcine inflammation and infection models. UCPH pig model network seminar
SPECT and PET imaging in porcine inflammation and infection models UCPH pig model network seminar Friday November 21. 2014, 8.30 12.00, auditorium A2 70.02, Thorvaldsensvej 40, 1871 Frederiksberg C. See
More informationA Letter from MabVax Therapeutics President and Chief Executive Officer
A Letter from MabVax Therapeutics President and Chief Executive Officer Dear Fellow Stockholder: You have invested in MabVax Therapeutics because you share our passion for finding new therapies for the
More informationProstate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
More informationEvaluation of the role of gene polymorphisms in anticancer drug efficacy using in vitro models
Group members and Contact details Jacques Robert graduated in medicine from the University of Strasbourg in 1974 and received hi Research projects: The objectives of our group are: (1) to identify preclinical
More informationUnderstanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient
Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that
More informationThe application of nanotechnology in the treatment of Rheumatoid Arthritis and Osteoarthritis. By Aniketa Khushu PASS WITH MERIT
The application of nanotechnology in the treatment of Rheumatoid Arthritis and Osteoarthritis By Aniketa Khushu PASS WITH MERIT Research Paper based on Pathology Lectures at Medlink 2010 1 Abstract: Introduction:
More informationLIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
More informationPharmaceutical Nanotechnology
Pharmaceutical Nanotechnology Pharmaceutical Nanotechnology Development of Gold-Chitosan-coated PLGA Nanoparticles Marius Hittinger 28.04.2011 Supervisor: Juniorprofessor Dr. Marc Schneider Pharmaceutical
More informationImmunotherapy Concept Turned Reality
Authored by: Jennifer Dolan Fox, PhD VirtualScopics Inc. jennifer_fox@virtualscopics.com +1 585 249 6231 Immunotherapy Concept Turned Reality Introduction While using the body s own immune system as a
More informationNational Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute
More informationMonoclonal Antibodies in Cancer. Ralph Schwall, PhD Associate Director, Translational Oncology Genentech, Inc.
Monoclonal Antibodies in Cancer Ralph Schwall, PhD Associate Director, Translational Oncology Genentech, Inc. Disclaimer I had nothing to do with Herceptin Using lessons learned in new antibody projects
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationa Phase 2 prostate cancer clinical trial is ongoing. Table 2: Squalamine vs Standard-of-care literature
PRODUCT FACT SHEET Spring 2007 MISSION STATEMENT Genaera Corporation is a biopharmaceutical company with a focus on metabolic and respiratory diseases. The compounds in the Genaera pipeline address signal
More informationTABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
More informationCytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
More informationA New Era for Cancer Treatment: Gold-Nanoparticle- Mediated Thermal Therapies
Photothermal Therapy A New Era for Cancer Treatment: Gold-Nanoparticle- Mediated Thermal Therapies Laura C. Kennedy, Lissett R. Bickford, Nastassja A. Lewinski, Andrew J. Coughlin, Ying Hu, Emily S. Day,
More informationMaking the switch to a safer CAR-T cell therapy
Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction
More informationIntroduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
More informationWhat You Need to Know About Lung Cancer Immunotherapy
What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer
More informationChemical Engineering. Ohio Academic Content Standards Grade. Lesson Summary:
Chemical Engineering Lesson Summary: Chemical engineering involves the design, construction, and operation of plants and machinery to make products such as acids, dyes, drugs, plastics, and synthetic materials.
More informationMATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION
MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION Nadia Terranova UNIVERSITÀ DI PAVIA New model development: course of action
More informationMultiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
More informationUpdate in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
More informationSkin cancer Patient information
Skin cancer Patient information What is cancer? The human body is made up of billions of cells. In healthy people, cells grow, divide and die. New cells constantly replace old ones in an orderly way. This
More informationOsteosarcoma: treatment beyond surgery
Osteosarcoma: treatment beyond surgery Eric Chow, DVM DACVS Sue Downing, DVM DACVIM-Oncology Providing the best quality care and service for the patient, the client, and the referring veterinarian. Osteosarcoma
More informationwww.iproteos.com Corporate Presentation November, 2013
www.iproteos.com Corporate Presentation November, 2013 The company Iproteos is an early-stage drug development company founded in 2011: Spin-Out from Institute for Research in Biomedicine (IRB Barcelona)
More informationThymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
More informationWhat is nanotoxicology?
What is nanotoxicology? How to estimate the potential hazard related to nanoparticles? Dissemination report October 2008 DR-225 200810-5 Project ID NMP2-CT-2005-515843 An European Integrated Project Supported
More informationFAQ About Prostate Cancer Treatment and SpaceOAR System
FAQ About Prostate Cancer Treatment and SpaceOAR System P. 4 Prostate Cancer Background SpaceOAR Frequently Asked Questions (FAQ) 1. What is prostate cancer? The vast majority of prostate cancers develop
More informationIndividualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But
More informationCHAPTER 2: UNDERSTANDING CANCER
CHAPTER 2: UNDERSTANDING CANCER INTRODUCTION We are witnessing an era of great discovery in the field of cancer research. New insights into the causes and development of cancer are emerging. These discoveries
More informationUnderstanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
More informationLung Cancer Research: From Prevention to Cure!
Lung Cancer Research: From Prevention to Cure! Ravi Salgia, M.D, Ph.D Associate Professor of Medicine Director, Thoracic Oncology Research Program Department of Medicine Section of Hematology/Oncology
More informationProstate Cancer Guide. A resource to help answer your questions about prostate cancer
Prostate Cancer Guide A resource to help answer your questions about prostate cancer Thank you for downloading this guide to prostate cancer treatment. We know that all the information provided online
More informationName Date Class CHAPTER 1 REVIEW. Answer the following questions in the space provided.
CHAPTER 1 REVIEW Matter and Change SECTION 1 SHORT ANSWER Answer the following questions in the space provided. 1. a Technological development of a chemical product often (a) lags behind basic research
More informationAn Introduction To Immunotherapy And The Promise Of Tissue Phenomics
An Introduction To Immunotherapy And The Promise Of Tissue Phenomics INSIDE: n The Potential of Immunotherapy n Towards an Understanding of Immunotherapy n Current Approaches to Immunotherapy n The Immunotherapy
More informationContact Information Korea Health Industry Development Institute
AGM-130, a novel CDK inhibitor with a marked anti-tumor activity and reduced toxicity, targeting the triple negative breast cancer(tnbc) and tamoxifen-resistant estrogen receptor (ER) positive breast cancer
More informationUnderstanding How Existing and Emerging MS Therapies Work
Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of
More informationCD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy
CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,
More informationTargeted Therapies in Lung Cancer
Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why
More informationUsing Family History to Improve Your Health Web Quest Abstract
Web Quest Abstract Students explore the Using Family History to Improve Your Health module on the Genetic Science Learning Center website to complete a web quest. Learning Objectives Chronic diseases such
More informationPaclitaxel-Loaded Expansile Nanoparticles Enhance Chemotheraputic Drug-delivery in Mesothelioma 3D Multicellular Spheroids
Paclitaxel-Loaded Expansile Nanoparticles Enhance Chemotheraputic Drug-delivery in Mesothelioma 3D Multicellular Spheroids Hongyi Lei 1, Rong Liu 1, Aaron Colby 2, Mark W. Grinstaff 2, Yolonda L. Colson
More informationExelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference
Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Clinical Programs and Significant Expansion of Cancer Pipeline Planned for 2004 SOUTH SAN FRANCISCO, Calif., Jan. 13 /PRNewswire-FirstCall/
More informationPolicy statement. Stem cell research
Policy statement Stem cell research Introduction For some people who survive a heart attack, the damage to their heart muscle can lead to debilitating heart failure, for which there is no cure. Nearly
More information2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
More informationAC 2011-523: MEDICAL PHYSICS CURRICULUM FOR UNDERGRAD- UATE ENGINEERING STUDENTS
AC 2011-523: MEDICAL PHYSICS CURRICULUM FOR UNDERGRAD- UATE ENGINEERING STUDENTS Renat Letfullin, Rose-Hulman Institute of Technology Renat R. Letfullin is associate professor of physics and optical engineering
More informationInvestor Presentation NASDAQ:BLFS
Investor Presentation NASDAQ:BLFS Safe Harbor Statement This presentation contains forward-looking statements, including, but not limited to, statements concerning the company s anticipated business and
More informationAutomating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
More informationRecruitment Start date: April 2010 End date: Recruitment will continue until enrolment is fully completed
Apitope study The study drug (ATX-MS-1467) is a new investigational drug being tested as a potential treatment for relapsing forms of multiple sclerosis (RMS). The term investigational drug means it has
More informationCancer: DNA Synthesis, Mitosis, and Meiosis
Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue
More informationUnderstanding. Pancreatic Cancer
Understanding Pancreatic Cancer Understanding Pancreatic Cancer The Pancreas The pancreas is an organ that is about 6 inches long. It s located deep in your belly between your stomach and backbone. Your
More informationGenScript Antibody Services
GenScript Antibody Services Scientific experts, innovative technologies, proven performance We specialize in custom antibody production to empower your research Custom Polyclonal Antibody Production Custom
More informationTowards Well-Defined ADCs (Antibody Drug Conjugates)
Towards Well-Defined ADCs (Antibody Drug Conjugates) Next generation approach June 10, 2015 Dr. Yong Zu Kim, CEO and President LegoChem Biosciences, Inc. Antibody Drug Conjugates ADC binds to Antigen Endocytosis
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More informationCancer patients waiting for potentially live-saving treatments in UK
Cancer patients waiting for potentially live-saving treatments in UK 29 May 2005 UK patients are waiting too long for new treatments, according to a 'Dossier of Delay' compiled by information charity CancerBACUP.
More informationWhat is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
More information19. Drug Treatment Trials
1 9. D R U G T R E A T M E N T T R I A L S 19. Drug Treatment Trials The science behind the Progeria clinical drug trials Trial medications at a glance Progeria clinical drug trials The science behind
More informationHUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE
HUNTINGTON S DISEASE MULTIDISCIPLINARY CLINIC HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE From gene to treatments The gene that causes Huntington s disease (HD) was discovered in 1993. Since then, enormous
More informationBasic Overview of Preclinical Toxicology Animal Models
Basic Overview of Preclinical Toxicology Animal Models Charles D. Hebert, Ph.D., D.A.B.T. December 5, 2013 Outline Background In Vitro Toxicology In Vivo Toxicology Animal Models What is Toxicology? Background
More informationPRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology
PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI
More informationNew Advances in Cancer Treatments. March 2015
New Advances in Cancer Treatments March 2015 Safe Harbour Statement This presentation document contains certain forward-looking statements and information (collectively, forward-looking statements ) within
More informationHyStem. Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH. esibio.com
HyStem Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH HyStem Hydrogel Extracellular Matrices Chemically-defined For use in 2D and 3D formats in vitro and in vivo applications Customizable for many
More informationYour Immune System & Lung Cancer Treatment
Your Immune System & Lung Cancer Treatment Immunotherapy and Lung Cancer Immunotherapy is quickly developing as an important approach to treating many forms of cancer, including lung cancer. Immunotherapy
More information20.309: Biological Instrumentation and Measurement. Heejin Choi Rumi Chunara Yuri Matsumoto
20.309: Biological Instrumentation and Measurement Instructors: Laboratory Instructor: Teaching Assistants: Scott Manalis and Peter So Steve Wasserman Jaewon Cha Heejin Choi Rumi Chunara Yuri Matsumoto
More informationPreventive Telemedicine Challenges in Russia
Preventive Telemedicine Challenges in Russia Sergey Koldybaev Siberian Branch of Russian Academy of Sciences E mail: phyto@list.ru Features of Russian Healthcare Most of qualified physicians concentrate
More informationMANAGING ANEMIA. When You Have Kidney Disease or Kidney Failure. www.kidney.org
MANAGING ANEMIA When You Have Kidney Disease or Kidney Failure www.kidney.org About the Information in this Booklet Did you know that the National Kidney Foundation (NKF) offers guidelines and commentaries
More informationTherapeutic Goods Administration Orphan Drugs Program: Discussion paper
Therapeutic Goods Administration Orphan Drugs Program: Discussion paper Submission from the Clinical Oncology Society of Australia and Cancer Council Australia March 2015 The Clinical Oncology Society
More informationGastric Cancer. Brochure More information from http://www.researchandmarkets.com/reports/2228929/
Brochure More information from http://www.researchandmarkets.com/reports/2228929/ Gastric Cancer Description: Gastric cancer (GC) is one of the most common malignancies in terms of incidence and the second
More informationGraphene for healthcare
By Del Stark and Jon Evans Del Stark Technology Solutions and JE Science Ltd, March 2014 All rights reserved: no part of this publication may be reproduced or transmitted in any form or by any means, electronic,
More informationOn the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma
On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma Uber die Entstehung von multinuklearen Reed-Sternberg Riesenzellen und die Rolle von CD4 T-Zellen
More informationFuture Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
More informationLeukemia Drug Pathway Analyzer
Brochure More information from http://www.researchandmarkets.com/reports/2673689/ Leukemia Drug Pathway Analyzer Description: Extra value: One year of free online updates included with this product There
More informationFGF-1 as Cosmetic Supplement
FGF-1 as Cosmetic Supplement Ing-Ming Chiu, Ph.D. Professor, Internal Medicine and Molecular and Cellular Biochemistry The Ohio State University Columbus, Ohio, U.S.A. GENTEON USA Fibroblast Growth Factor
More informationAPA format (title page missing) Proton Therapy 3. A paper. A New Cancer Treatment: Proton Therapy. A Review of the Literature
APA format (title page missing) Proton Therapy 3 A paper A New Cancer Treatment: Proton Therapy A Review of the Literature Cancer is a widespread disease that is defined as a malignant or invasive growth
More informationFuture strategies for myeloma: An overview of novel treatments In development
Future strategies for myeloma: An overview of novel treatments In development Dr. Matthew Streetly Guys and St. Thomas NHS Trust How far have we come? Melphalan and prednisolone VAD Autologous SCT Thalidomide
More informationLauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
More informationguides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research
infoaging guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research WHAT ARE STEM CELLS? Stem cells are cells that, in cell cultures
More informationGraduate Programs in Physics and Astronomy
Graduate Programs in Physics and Astronomy Western s award winning faculty members, cutting edge research and interdisciplinary environment give you the tools to engage your imagination. The University
More information